Literature DB >> 7653556

Receptor discrimination and control of agonist-antagonist binding.

R J Tallarida1.   

Abstract

The law of mass action is the common model for the interaction of agonist and antagonist compounds with cellular receptors. Parameters of the interaction, obtained from functional and radioligand-binding studies, allow discrimination and subtyping of receptors and aid in understanding specific mechanisms. This article reviews the theory and associated mathematical models and graphical transformations of data that underlie the determination of receptor parameters. The main theory assumes that agonist and antagonist compounds bind to cells that have a fixed number of receptors and provides the framework for obtaining drug-receptor parameters from data and their graphical transformations. Conditions that produce a change in receptor number, a newer concept in pharmacology, can have an important effect on the parameter values derived in the usual way. This review concludes with a discussion of the quantitative study of receptor-mediated feedback control of endogenous ligands, a very new topic with potentially important implications for understanding antagonist effectiveness, loss of control, and chaos in regulated mass action binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7653556     DOI: 10.1152/ajpendo.1995.269.2.E379

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.

Authors:  P W Manley; C Löffler-Walz; U Russ; A Hambrock; T Moenius; U Quast
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Squared correlation coefficient of measured values versus predicted values in linear and monoexponential regressions.

Authors:  Guang Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Apr-Jun       Impact factor: 2.441

3.  Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibition.

Authors:  U Russ; P Kühner; R Prager; D Stephan; J Bryan; U Quast
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

4.  Binding of [3H]-P1075, an opener of ATP-sensitive K+ channels, to rat glomerular preparations.

Authors:  F Metzger; U Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

5.  Patterns of nicotinic receptor antagonism: nicotine discrimination studies.

Authors:  Emily M Jutkiewicz; Emily A Brooks; Adam D Kynaston; Kenner C Rice; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2011-07-05       Impact factor: 4.030

6.  Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic K(ATP) channel.

Authors:  Petra Kühner; Renate Prager; Damian Stephan; Ulrich Russ; Marcus Winkler; David Ortiz; Joseph Bryan; Ulrich Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-15       Impact factor: 3.000

7.  Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.

Authors:  X H Chen; L Y Liu-Chen; R J Tallarida; E B Geller; J K de Riel; M W Adler
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.